$OM

Leonard Braden Michael purchased $870K of OM (indirect holdings)

Leonard Braden Michael purchased 244,909 indirectly-held shares of Outset Medical, Inc. (OM) at an average of $3.55 ($3.53–$3.88, $0.87M total) across 2 trades over 2026-10-01 to 2026-10-02.

Original reporting
SEC EDGAR · Leonard Braden Michael
Published Oct 5, 2026, 11:24 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 11:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$OM
Bullish
high confidence
Mentioned
$OM
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OMBullishLow
01

Why it matters

The insider buy adds a positive data point for Outset Medical, potentially influencing short‑term sentiment.

02

Market read

A material insider purchase by a major shareholder could provide a short‑term price boost.

03

What to watch

The transaction size is modest in absolute dollars and may not move the stock significantly on its own.

Relevance 6/10Novelty 7/10Timing: today

Background

Form 4 filings disclose insider transactions and are considered primary sources of material information.

Company-level read

Ticker impact

$OMBullishHigh confidence
Context

10% owner Leonard Braden Michael bought 244,909 shares of Outset Medical for $870K, increasing his stake to 2,764,610 shares.

Expected impact

likely upward pressure as the market prices in the insider buy.

Evidence & confidence

The buyer is a 10% owner, the purchase size is material relative to the insider's holdings, and the transaction was disclosed via a Form 4 on the filing day.

Market effects

May reinforce confidence in the medical device sector if other insiders follow suit.

Limited to U.S. markets where Outset Medical trades.

Minimal global impact beyond the company's own stock.

Counterpoint

The purchase could be a routine portfolio rebalancing rather than a strong bullish signal.

Key entities

  • Leonard Braden Michael

    10% owner of Outset Medical who made the purchase.

  • Outset Medical, Inc.

    Medical device company whose stock ticker is OM.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$OMMedAI 8/10

Outset Medical (OM) Q2 2026 Earnings Call Transcript

Outset Medical (OM) reported Q2 2026 revenue of $31.6 million, up 1% year over year and 14% sequentially. Console revenue was $9.5 million, up 6% YoY, while product revenue fell 5% to $21.9 million. Non-GAAP gross margin was 42.2%. Cash and investments were $151 million. Full-year revenue guidance is $125 million to $130 million.

$OMMed

Outset Medical Reports Second Quarter 2026 Results

Outset Medical, Inc. (OM) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Outset Medical Reports Second Quarter 2026 Results San Jose, CA – August 6, 2026 – Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today

$AEMMed

Tuesday’s analyst upgrades and downgrades

National Bank Financial analysts revised precious-metals and copper forecasts ahead of Q2 earnings, citing realized gold at $4,508/oz and silver at $73/oz, and copper at $5.82/lb. They cut 2026 gold and silver assumptions and adjusted target prices for multiple miners, generally lower. TD Cowen upgraded First Quantum Minerals on a likely Cobre Panama restart by year-end.

$OMMed

Outset Medical, Inc. (OM): Results of Operations and Financial Condition

Outset Medical, Inc. (OM) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-10.1 2 om-ex10_1.htm EX-10.1 EX-10.1 Exhibit 10.1 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND REPLACED WITH “[***]”. SUCH IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) THE TYPE OF INFORMATION THA